Advertisement

The Role of Thyroid Scintigraphy in the Evaluation of Thyroid Nodules in Patients with Normal TSH

  • Levent Kabasakal
  • Onur Erdem Şahin
Chapter

Abstract

The widespread use of imaging modalities such as ultrasonography (USG), magnetic resonance imaging (MRI), and computer tomography (CT) has significantly increased thyroid nodule detection. Thyroid nodules are generally benign, but identification of malignant nodules is an important clinical problem. Nodules with hyperfunction on thyroid scintigraphy, also known as autonomously functioning thyroid nodules (AFTNs), are often considered as benign.

The American Thyroid Association (ATA) Guideline, revised in 2015, recommends thyroid scintigraphy only in conditions with subnormal TSH values. On the contrary, the American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical (AACE/ACE/AME) guidelines recommend to perform thyroid scan in iodine-deficient regions, to exclude an autonomous thyroid nodule or MNG even when the TSH level is low-normal.

Especially in areas with iodine deficiency, it has been shown that AFTNs can be seen with the TSH values in the normal range. As in the cases from Turkey, an iodine deficiency area, AFTNs are detected, although TSH values are monitored in the normal range. Avoiding from thyroid scintigraphy in cases with normal TSH values in the direction of ATA guideline can cause some AFTNs to be missed. The unnecessary biopsies resulting from indeterminate reports like AUS and FLUS can lead to unnecessary operations. For these reasons, thyroid scintigraphy has an important role in the detection of AFTN, especially in iodine deficiency areas.

Keywords

AFTNs Thyroid scan Hot nodule TSH Iodine deficiency Hyperfunction 

References

  1. 1.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.  https://doi.org/10.1089/thy.2015.0020.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Levine RA. Current guidelines for the management of thyroid nodules. Endocr Pract. 2012;18:596–9.  https://doi.org/10.4158/ep12071.co.CrossRefPubMedGoogle Scholar
  3. 3.
    Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008;22:901–11.  https://doi.org/10.1016/j.beem.2008.09.019.CrossRefPubMedGoogle Scholar
  4. 4.
    Hegedüs L. The thyroid nodule. N Engl J Med. 2004;351:1764–71.  https://doi.org/10.1056/NEJMcp031436.CrossRefPubMedGoogle Scholar
  5. 5.
    Mandel SJ. A 64-year-old woman with a thyroid nodule. JAMA. 2004;292:2632–42.  https://doi.org/10.1001/jama.292.21.2632.CrossRefPubMedGoogle Scholar
  6. 6.
    Raza SN, Shah MD, Palme CE, Hall FT, Eski S, Freeman JL. Risk factors for well-differentiated thyroid carcinoma in patients with thyroid nodular disease. Otolaryngol Head Neck Surg. 2008;139:21–6.  https://doi.org/10.1016/j.otohns.2007.10.021.CrossRefPubMedGoogle Scholar
  7. 7.
    Pacini F, Vorontsova T, Demidchik EP, Molinaro E, Agate L, Romei C, et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab. 1997;82:3563–9.  https://doi.org/10.1210/jcem.82.11.4367.CrossRefPubMedGoogle Scholar
  8. 8.
    Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules – 2016 update. Endocr Pract. 2016;22(Suppl 1):1–60.  https://doi.org/10.4158/EP161208.GL.CrossRefGoogle Scholar
  9. 9.
    Treglia G, Trimboli P, Verburg FA, Luster M, Giovanella L. Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule. Eur J Clin Investig. 2015;45:739–44.  https://doi.org/10.1111/eci.12456.CrossRefGoogle Scholar
  10. 10.
    Chami R, Moreno-Reyes R, Corvilain B. TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients. Eur J Endocrinol. 2014;170:593–9.CrossRefGoogle Scholar
  11. 11.
    Belfiore A, Sava L, Runello F, Tomaselli L, Vigneri R. Solitary autonomously functioning thyroid nodules and iodine deficiency. J Clin Endocrinol Metabol. 1983;56:283–7.  https://doi.org/10.1210/jcem-56-2-283.CrossRefGoogle Scholar
  12. 12.
    Mirfakhraee S, Mathews D, Peng L, Woodruff S, Zigman JM. A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature. Thyroid Res. 2013;6:7.  https://doi.org/10.1186/1756-6614-6-7.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Moreno-Reyes R, Kyrilli A, Lytrivi M, Bourmorck C, Chami R, Corvilain B. Is there still a role for thyroid scintigraphy in the workup of a thyroid nodule in the era of fine needle aspiration cytology and molecular testing? F1000Research. 2016;5:F1000 Faculty Rev-763.  https://doi.org/10.12688/f1000research.7880.1.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Nuclear Medicine, Cerrahpaşa Faculty of Medicineİstanbul UniversityIstanbulTurkey

Personalised recommendations